Nippon Shinyaku Co., Ltd. (NPNKF)

OTCMKTS · Delayed Price · Currency is USD
37.75
+7.24 (23.73%)
At close: Dec 9, 2025
Market Cap2.25B +36.0%
Revenue (ttm)1.06B +5.9%
Net Income190.38M -1.8%
EPS2.83 -1.9%
Shares Outn/a
PE Ratio11.84
Forward PEn/a
Dividend0.82 (2.69%)
Ex-Dividend DateMar 30, 2026
Volume300
Average Volume1,131
Open37.75
Previous Close30.51
Day's Range37.75 - 37.75
52-Week Range21.00 - 38.01
Beta-0.28
RSIn/a
Earnings DateFeb 9, 2026

About Nippon Shinyaku

Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. It offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases; health food ingredients, preservatives, protein preparations, and supplements. The company in the Strategic Partnership with Nippon Shinyaku to develop ATSN-10 that is in Phase I/II of clinical trials for the treatment of GUCY2D-mutant Leb... [Read more]

Sector Healthcare
Founded 1911
Employees 2,243
Stock Exchange OTCMKTS
Ticker Symbol NPNKF
Full Company Profile

Financial Performance

In fiscal year 2025, Nippon Shinyaku's revenue was 160.23 billion, an increase of 8.08% compared to the previous year's 148.26 billion. Earnings were 32.56 billion, an increase of 25.94%.

Financial numbers in JPY Financial Statements